Active · per the CBE, 31 October 2026

NXTLAB

BE1006873757

Rechtspersoon Private limited company 1 establishment

NXTLAB is a research organisation in Roeselare. Private Limited, started on 7 March 2024, 1 establishment.

Deltalaan 1, 8800 Roeselare

Behind the company: Elmace BV, SA Artsen BV, An-Sofie Decavele BV, LabMed DDS BV+8.

Active for

2 year, 7 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    39 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

NXTLAB from Roeselare, company number BE1006873757, closed financial year 2025 with a result of € 114,009 after tax. For that financial year NXTLAB recorded a gross margin of € 114,641 and equity of € 1,389. Compared with financial year 2024, the result moved from € 21,181 to € 114,009. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What it is worth Growing

€ 1,389

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 114,009

▲ € 92,828 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 82,501

▲ € 68,778 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 114,000 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,763

▲ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 38

▼ 37% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
20242025Change 2024 → 2025
Gross margin € 25,079 € 114,641 ▲ € 89,562
Profit after taxes € 21,181 € 114,009 ▲ € 92,828
Equity € 1,381 € 1,389 ▲ 1%
Total debts € 23,060 € 117,800 ▲ € 94,740
Cash € 13,723 € 82,501 ▲ € 68,778
Retained profit € 181 € 189 ▲ 5%
Dividend € 21,000 € 114,000 ▲ € 93,000
Balance sheet total € 24,441 € 119,190 ▲ € 94,749

Key figures of NXTLAB, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NXTLAB?

What happened at NXTLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 114,009 (▲ € 92,828 vs 2024). Source: NBB ↗
  • New establishment in Roeselare. KBO
  • Elmace BV became a director. NBB
  • SA Artsen BV became a director. NBB
  • An-Sofie Decavele BV became a director. NBB
  • LabMed DDS BV became a director. NBB
  • Inpe Farma BV became a director. NBB
  • Frederik Van Hoecke BV became a director. NBB

In short

From € 21,181 profit in 2024 to € 114,009 profit in 2025.

Paid € 98 in corporate taxes since 2024.

Best year ever: 2025, with € 114,009 profit.

Paid out € 135,000 in dividends to the owners in total.

Management

Behind NXTLAB are Elmace BV, SA Artsen BV, An-Sofie Decavele BV, LabMed DDS BV, Inpe Farma BV and Frederik Van Hoecke BV.

Directors

According to the 2025 annual accounts

Elmace BV

Director · represented by Eline Verhoye

since 2024

SA Artsen BV

Director · represented by Steven Vervaeke

since 2024

An-Sofie Decavele BV

Director · represented by An-Sofie Decavele

since 2024

LabMed DDS BV

Director · represented by Dieter De Smet

since 2024

Inpe Farma BV

Director · represented by Inge De Cuyper

Also active at: BOUCKAERT - MEKEIRELE

since 2024

Frederik Van Hoecke BV

Director · represented by Frederik Van Hoecke

since 2024

DR Inge Van Haute BV

Director · represented by Inge Van Haute

since 2024

Hilde Vanpoucke - Apotheker Klinisch Bioloog BV

Director · represented by Hilde Vanpoucke

since 2024

DR. E. DE LAERE BV

Director · represented by Emmanuel De Laere

since 2024

Johan Debrabandere - Apotheker Klinisch Bioloog BV

Director · represented by Johan Debrabandere

since 2024

Dr. Vercruysse-Vandenbussche BV

Director · represented by Hilde Vandenbussche

since 2024

Cytomics Consulting BV

Director · represented by Geert Martens

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Deltalaan 1

8800 Roeselare

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1006.873.757
VAT number
BE 1006.873.757
Registered office
Deltalaan 1, 8800 Roeselare
Names & denominations
NXTLAB
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
7 March 2024
Peppol
Active · Active since 19 Nov 2025
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What does NXTLAB do?
NXTLAB is a research organisation in Roeselare. Private Limited, started on 7 March 2024, 1 establishment.
What is the address of NXTLAB?
The registered office of NXTLAB is located at Deltalaan 1, 8800 Roeselare.
Is NXTLAB still active?
Yes. According to the CBE (31 October 2026) NXTLAB is active, legal situation “Normale toestand”, started on 7 March 2024.
Is NXTLAB registered on Peppol?
Yes, NXTLAB is registered on the Peppol network with ID 0208:1006873757.
What is the enterprise number of NXTLAB?
The enterprise number of NXTLAB is BE1006873757.
When was NXTLAB founded?
NXTLAB was founded on 7 March 2024.